Gomez-Randulfe I, Scanlon LA, Carter M, Moliner L, et al. First-line osimertinib compared to earlier generation TKIs in advanced EGFR-mutant NSCLC: A real-world survival analysis. Lung Cancer 2025;200:108084.
PMID: 39823701